Philadelphia chromosome and the role it plays in chronic myeloid leukaemia

Treatment of acute lymphoblastic leukaemia by activation of patient's immune cells by a bispecific antibody

Novel targeting in acute myeloid leukaemia

Better understandings of gene mutations aid diagnostic tools in CLL

Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL

Comment: Advances in haematological cancer presented at EHA 2014

Advances in chronic lymphocytic leukaemia: Expert panel discussion

Genetically modified T cells fight haematological cancer

Investigating anticarcinogenic compounds as an alternative to chemo

HPV-targeted adoptive T Cell therapy for advanced cervical cancer

PD-1 targeting immunotherapy MK-3475 has high, long-lasting activity against metastatic melanoma

Ipilimumab and nivolumab achieves long-term survival in advanced melanoma